Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

OBJECTIVE: Prostate secretory protein of 94 amino acids (PSP94) is a target gene of the EZH2 transcriptional repressor and is often downregulated in prostate cancer; however, its prognostic value is disputed. METHODS: Immunohistochemical analysis of a tissue microarray of 12, 432 prostate cancer spe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Biol Med
Päätekijät: Luebke, Andreas M., Attarchi-Tehrani, Ali, Meiners, Jan, Hube-Magg, Claudia, Lang, Dagmar S., Kluth, Martina, Tsourlakis, Maria Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Büscheck, Franziska, Jacobsen, Frank, Hinsch, Andrea, Steurer, Stefan, Schlomm, Thorsten, Huland, Hartwig, Graefen, Markus, Haese, Alexander, Heinzer, Hans, Clauditz, Till S., Burandt, Eike, Wilczak, Waldemar, Höflmayer, Doris
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Chinese Anti-Cancer Association 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713635/
https://ncbi.nlm.nih.gov/pubmed/31516752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2018.0384
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia